GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (NSE:SHILPAMED) » Definitions » Return-on-Tangible-Asset

Shilpa Medicare (NSE:SHILPAMED) Return-on-Tangible-Asset : 2.11% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Shilpa Medicare Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Shilpa Medicare's annualized Net Income for the quarter that ended in Mar. 2025 was ₹580 Mil. Shilpa Medicare's average total tangible assets for the quarter that ended in Mar. 2025 was ₹27,461 Mil. Therefore, Shilpa Medicare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was 2.11%.

The historical rank and industry rank for Shilpa Medicare's Return-on-Tangible-Asset or its related term are showing as below:

NSE:SHILPAMED' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1.34   Med: 7.54   Max: 12.48
Current: 2.96

During the past 13 years, Shilpa Medicare's highest Return-on-Tangible-Asset was 12.48%. The lowest was -1.34%. And the median was 7.54%.

NSE:SHILPAMED's Return-on-Tangible-Asset is ranked better than
51.47% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.67 vs NSE:SHILPAMED: 2.96

Shilpa Medicare Return-on-Tangible-Asset Historical Data

The historical data trend for Shilpa Medicare's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare Return-on-Tangible-Asset Chart

Shilpa Medicare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.36 2.58 -1.34 1.27 2.94

Shilpa Medicare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 2.18 2.77 4.90 2.11

Competitive Comparison of Shilpa Medicare's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Return-on-Tangible-Asset falls into.


;
;

Shilpa Medicare Return-on-Tangible-Asset Calculation

Shilpa Medicare's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=782.93/( (25857.564+27460.601)/ 2 )
=782.93/26659.0825
=2.94 %

Shilpa Medicare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=580.364/( (0+27460.601)/ 1 )
=580.364/27460.601
=2.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Shilpa Medicare  (NSE:SHILPAMED) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Shilpa Medicare Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Shilpa Medicare's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines